Krystal Biotech, Inc. (NASDAQ: KRYS) today announced that it has priced the previously announced underwritten public offering of 2,500,000 shares ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE